Motherly app shows stronger depressive symptom reduction in women with fewer children and higher pediatric consultations
This study was a secondary analysis of a randomized controlled trial involving 264 women. The intervention was the Motherly app, compared to an active control group. The primary outcome was depressive symptoms assessed by the Edinburgh Postnatal Depression Scale. The secondary outcome was functional impairment by the Clinical Global Impression.
The main results indicated that intervention effects were moderated by the number of children and pediatric consultations. Stronger effects were observed among mothers with fewer children and higher consultation frequency. Additionally, effects were moderated by time spent with the child, with greater improvements among mothers with lower caregiving demands. Total and BA achievements were significantly associated with reduction in depressive symptoms. BA and RCPR mediated the effect of the intervention.
Safety and tolerability data were not reported. Serious adverse events, discontinuations, and general tolerability were not reported. No specific adverse event rates were provided. The study limitations were not reported. Funding or conflicts of interest were not reported. The certainty of the findings regarding subgroup effects is moderate due to the observational nature of the moderation analysis within a trial framework.
The practice relevance is that clinicians should consider the Motherly app for postpartum depression, noting that benefits may be more pronounced in women with fewer children and higher pediatric consultation frequency. Functional impairment benefits may be greater in women with lower caregiving demands.